---
figid: PMC3364444__leu2011282f1
figtitle: N-BPs may modulate myeloma progression through their effects on the mevalonate
  pathway and directly on MM plasma cells, bone marrow cells and immune cells in the
  bone marrow
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Cladophora subtilissima
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
pmcid: PMC3364444
filename: leu2011282f1.jpg
figlink: /pmc/articles/PMC3364444/figure/fig1/
number: F1
caption: N-BPs may modulate myeloma progression through their effects on the mevalonate
  pathway and directly on MM plasma cells, bone marrow cells and immune cells in the
  bone marrow. (a) N-BPs affect cell survival by blocking the key enzyme (that is,
  FPPS) in the mevalonate pathway required for prenylation of proteins., ,  (b) N-BPs
  prevent proliferation of MM plasma cells directly via inhibition of growth factors
  that promote cell growth and survival within the bone microenvironment and indirectly
  via inhibition of angiogenesis (left)., , , , ,  N-BPs enhance host antitumor immune
  response (right). The dotted line depicts the boundary between the bone microenvironment
  and the extraskeletal vasculature. bFGF, fibroblast growth factor; FPPS, farnesyl
  pyrophosphate synthase; HGF, hepatocyte growth factor; IGF-1, insulin-like growth
  factor-1; N-BP, nitrogen-containing bisphosphonate/aminobisphosphonate; NF-κB, nuclear
  factor-κB; PDGF, platelet-derived growth factor; TNF-α, tumor necrosis factor-α.
papertitle: Bisphosphonates as antimyeloma drugs.
reftext: N D Modi, et al. Leukemia. 2012 Apr;26(4):589-594.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9062276
figid_alias: PMC3364444__F1
figtype: Figure
redirect_from: /figures/PMC3364444__F1
ndex: b49c7862-df12-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3364444__leu2011282f1.html
  '@type': Dataset
  description: N-BPs may modulate myeloma progression through their effects on the
    mevalonate pathway and directly on MM plasma cells, bone marrow cells and immune
    cells in the bone marrow. (a) N-BPs affect cell survival by blocking the key enzyme
    (that is, FPPS) in the mevalonate pathway required for prenylation of proteins.,
    ,  (b) N-BPs prevent proliferation of MM plasma cells directly via inhibition
    of growth factors that promote cell growth and survival within the bone microenvironment
    and indirectly via inhibition of angiogenesis (left)., , , , ,  N-BPs enhance
    host antitumor immune response (right). The dotted line depicts the boundary between
    the bone microenvironment and the extraskeletal vasculature. bFGF, fibroblast
    growth factor; FPPS, farnesyl pyrophosphate synthase; HGF, hepatocyte growth factor;
    IGF-1, insulin-like growth factor-1; N-BP, nitrogen-containing bisphosphonate/aminobisphosphonate;
    NF-κB, nuclear factor-κB; PDGF, platelet-derived growth factor; TNF-α, tumor necrosis
    factor-α.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Agfg1
  - Rho
  - Rhod
  - Ea2
  - ras
  - Hras
  - Kras
  - Rem1
  - Vegfa
  - Igf1
  - Tnf
  - Nfkb1
  - NUBP1
  - TP63
  - COASY
  - AGFG1
  - RAB10
  - RAB11A
  - RAB11B
  - RAB12
  - RAB13
  - RAB14
  - RAB15
  - RAB17
  - RAB18
  - RAB19
  - RAB1A
  - RAB1B
  - RAB1C
  - RAB20
  - RAB21
  - RAB22A
  - RAB23
  - RAB24
  - RAB25
  - RAB26
  - RAB27A
  - RAB27B
  - RAB28
  - RAB2A
  - RAB2B
  - RAB30
  - RAB31
  - RAB32
  - RAB33A
  - RAB33B
  - RAB34
  - RAB35
  - RAB36
  - RAB37
  - RAB38
  - RAB39A
  - RAB39B
  - RAB3A
  - RAB3B
  - RAB3C
  - RAB3D
  - RAB40A
  - RAB40AL
  - RAB40B
  - RAB40C
  - RAB41
  - RAB42
  - RAB43
  - RAB44
  - RAB4A
  - RAB4B
  - RAB5A
  - RAB5B
  - RAB5C
  - RAB6A
  - RAB6B
  - RAB6C
  - RAB7A
  - RAB7B
  - RAB29
  - RAB8A
  - RAB8B
  - RAB9A
  - RAB9B
  - RABL2A
  - RABL2B
  - RABL3
  - IFT22
  - RHO
  - RHOD
  - RHOA
  - RHOB
  - RHOC
  - KRAS
  - HRAS
  - NRAS
  - FDPS
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - IGF1
  - TNF
  - NFKB1
  - rab
  - Rab5
  - rho
  - Bx
  - Rho1
  - Lcp65Ab1
  - Ras64B
  - Ras85D
  - Fpps
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - egr
  - Dif
  - dl
  - Rel
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - tt
  - pyrophosphate
---
